F.D.A. Rejects Diet capsule in Setback for Obesity Drug Development

The Food and Drug Administration rejected another new diet
pill on Thursday, a decision that sharply diminished the
already scarce number of options available to overweight
Americans amid the nation's obesity epidemic.


The rejected drug, called Qnexa, is the third weight loss
drug to suffer a significant setback this month because of
concerns about safety, as federal regulators seem to have
heightened their scrutiny of diet pills that could pose risks
to the heart or other organs.